2KAMANGAR F, DORES GM, ANDERSON WF. Patterns of can- cer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geo- graphic regions of the world[J]. J Clin Oncol, 2006, 24(14): 2137-2150.
3HIGUCHI K, PI-IAN A, AJANI JA. Gastric cancer: advances in adjuvant and adjunct therapy[J]. Curr Treat Options Oncol. 2003, 4(5): 413-419.
5HARRIS L, FRITSCHE H, MENNEL R, et al. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer[J]. J Clin Oncol, 2007, 25(33): 5287-5312.
6HUDELIST G, KOSTLER W J, ATYEMS J, et al. Her-2/neu-triggered intracellular tyrosine kinase activation: in vi- vo relevance of ligand-independent activation mechanisms and impact upon the efficacy of trastuzumab-based treatment[J]. Br J Cancer, 2003, 89(6): 983-991.
